Metabolic shifts do not influence the glycosylation patterns of a recombinant fusion protein expressed in BHK cells.

BHK-21 cells expressing a human IgG-IL2 fusion protein, with potential application in tumor-targeted therapy, were grown under different nutrient conditions in a continuous system for a time period of 80 days. At very low-glucose (< 0.5 mM) or glutamine (< 0. 2 mM) concentrations, a shift toward an energetically more efficient metabolism was observed. Cell-specific productivity was maintained under metabolically shifted growth conditions and at the same time an almost identical intracellular ATP content, obtained by in vivo (31)P NMR experiments, was observed. No significant differences in the oligosaccharide structures were detected from the IgG-IL2 fusion protein preparations obtained by growing cells under the different metabolic states. By using oligosaccharide mapping and MALDI/TOF-MS, only neutral diantennary oligosaccharides with or without core alpha1-6-linked fucose were detected that carried no, one or two beta1-4-linked galactose. Although the O-linked oligosaccharide structures that are present in the IL2 moiety of the protein were studied with less detail, the data obtained from the hydrazinolysis procedure point to the presence of the classical NeuAcalpha2-3Galbeta1-3GalNAc structure. Here, it is shown that under different defined cellular metabolic states, the quality of a recombinant product in terms of O- and N-linked oligosaccharides is stable, even after a prolonged cultivation period. Moreover, unaffected intracellular ATP levels under the different metabolic states were observed.

[1]  H. Hauser,et al.  Dicistronic transcription units for gene expression in mammalian cells. , 1993, Gene.

[2]  H J Cruz,et al.  Metabolic shifts by nutrient manipulation in continuous cultures of BHK cells. , 1999, Biotechnology and bioengineering.

[3]  R. Dwek,et al.  Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein , 1995, Nature Medicine.

[4]  S L Morrison,et al.  Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1 , 1994, The Journal of experimental medicine.

[5]  R. Wagner,et al.  Ammonium ion and glucosamine dependent increases of oligosaccharide complexity in recombinant glycoproteins secreted from cultivated BHK-21 cells. , 1998, Biotechnology and bioengineering.

[6]  H. Vogel,et al.  Nuclear magnetic resonance studies of cellular metabolism. , 1990, Analytical biochemistry.

[7]  S. Shohet,et al.  Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. , 1988, The Journal of biological chemistry.

[8]  V. Wray,et al.  Structures of sialylated oligosaccharides of human erythropoietin expressed in recombinant BHK-21 cells. , 1993, European journal of biochemistry.

[9]  Gregory Stephanopoulos,et al.  Metabolic effects on recombinant interferon‐γ glycosylation in continuous culture of Chinese hamster ovary cells , 1999 .

[10]  M. Butler,et al.  Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody. , 1998, Journal of biotechnology.

[11]  R. Dwek,et al.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG , 1985, Nature.

[12]  E. Hounsell,et al.  The glycosylation pattern of a humanized IgGl antibody (D1.3) expressed in CHO cells , 1997, Glycoconjugate Journal.

[13]  R. Parekh,et al.  Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody. , 1992, The Biochemical journal.

[14]  R. Dwek,et al.  Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. , 1996, The Biochemical journal.

[15]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[16]  M. Nimtz,et al.  Carbohydrate structures of a human tissue plasminogen activator variant expressed in recombinant Chinese hamster ovary cells , 1990, FEBS letters.

[17]  R. Jefferis,et al.  Glycosylation of human IgG subclass and mouse IgG2b heavy chains secreted by mouse J558L transfectoma cell lines as chimeric antibodies. , 1993, Human antibodies and hybridomas.

[18]  M J Keen,et al.  Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions. , 1995, Glycobiology.

[19]  R. Wagner,et al.  Characterization of changes in the glycosylation pattern of recombinant proteins from BHK-21 cells due to different culture conditions. , 1995, Journal of biotechnology.

[20]  R. Jefferis,et al.  Comparative structural study of the N-linked oligosaccharides of human normal and pathological immunoglobulin G. , 1987, Biochemistry.

[21]  R. Geyer,et al.  Structures of the major carbohydrates of natural human interleukin-2. , 1985, European journal of biochemistry.

[22]  J. Lehmann,et al.  Influence of power input and aeration method on mass transfer in a laboratory animal cell culture vessel , 1995 .

[23]  R. Jefferis,et al.  Oligosaccharide‐protein interactions in IgG can modulate recognition by Fcγ receptors , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  M. Silberklang,et al.  Optimization of a Fed‐batch Process for Production of a Recombinant Antibody , 1994, Annals of the New York Academy of Sciences.

[25]  M. Carrondo,et al.  Metabolic responses to different glucose and glutamine levels in baby hamster kidney cell culture , 1999, Applied Microbiology and Biotechnology.

[26]  S L Morrison,et al.  Effect of glycosylation on antibody function: implications for genetic engineering. , 1997, Trends in biotechnology.

[27]  J. B. Griffiths,et al.  An integrated strategy for the process development of a recombinant antibody-cytokine fusion protein expressed in BHK cells , 1999, Applied Microbiology and Biotechnology.

[28]  M. Nimtz,et al.  Stable Expression of the Golgi Form and Secretory Variants of Human Fucosyltransferase III from BHK-21 Cells , 1997, The Journal of Biological Chemistry.